Alpha Tau Medical Ltd. Share Price

Alpha Tau Medical Ltd. Share Price

NASDAQ: DRTS
$13.11
-$0.28 (-2.09%) Last updated on 30 Oct, 2026 | 00:01 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Alpha Tau Medical Ltd. Stock Performance

Open
$13.49
Prev. Close
$13.39
Circuit Range
N/A
Day Range
$13.10 - $13.49
Year Range
$3.48 - $15.73
Volume
8,222
Average Traded
$13.28

Alpha Tau Medical Ltd. Share Price Today

As of 30 October 2026, Alpha Tau Medical Ltd.'s share price is $13.11. The stock opened at $13.49, compared to its previous close of $13.39. During today's trading session, Alpha Tau Medical Ltd.'s share price traded between $13.10 and $13.49, with an average price of $13.29. Over the past 52 weeks, the stock has recorded a high of $15.73 and a low of $3.48. In terms of performance, Alpha Tau Medical Ltd.'s share price has risen by 57.10% over the last six months and is up 213.26% on a year-on-year basis.

Alpha Tau Medical Ltd. Share Price Chart

Line chart of the Alpha Tau Medical Ltd. price trend over the selected period. The price fell overall, ranging from 13.07 to 13.49, ending at 13.11.
$13.10$13.49
L
Show Current Price
H

Alpha Tau Medical Ltd. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Alpha Tau Medical Ltd. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$33.76-$29.16-$31.75-$42.63
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A13.63%-8.88%-34.27%

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Alpha Tau Medical Ltd. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$14.70
$13.10
-12.20%
Sep 2026
$13.90
$14.91
+0.30%
Aug 2026
$11.67
$14.87
+26.23%
Jul 2026
$12.52
$11.78
-5.61%
Jun 2026
$10.84
$12.48
+15.13%
May 2026
$8.35
$10.84
+29.90%
Apr 2026
$6.87
$8.35
+19.04%
Mar 2026
$7.51
$7.01
-9.72%
Feb 2026
$6.99
$7.76
+13.86%
Jan 2026
$5.01
$6.82
+38.48%
Dec 2025
$3.91
$4.92
+24.68%
Nov 2025
$4.15
$3.95
-5.62%

DRTS Share Price FAQs